Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion

Abstract

Described herein are compositions and methods for the increasing the quantity of lipids secreted from meibomian glands. Such compositions and methods are useful for the treatment of meibomian gland dysfunction and disorders resulting therefrom.

1 - 30 . (canceled) 
     
     
         31 . A method for increasing lipid secretion from a meibomian gland, comprising topically administering to the eyelid margin of the patient in need thereof an ophthalmic composition comprising an ophthalmically-acceptable carrier and an effective amount of at least one agent which increases lipogenesis in the meibomian gland or increases lipid secretion from the meibomian gland, wherein the agent is thiorphan or tixocortol. 
     
     
         32 . The method of  claim 31 , wherein the ophthalmically-acceptable carrier comprises at least one ophthalmically-acceptable excipient. 
     
     
         33 . The method of  claim 31 , further comprising the step of administering to the patient a keratolytic agent. 
     
     
         34 . The method of  claim 33 , wherein the keratolytic agent is selected from the group consisting of benzoyl peroxide, coal tar, dithranol, salicylic acid, selenium disulfide, alpha-hydroxy acid, urea, boric acid, retinoic acid, lactic acid, sodium thioglycolate or allantoin. 
     
     
         35 . The method of  claim 31 , wherein the agent is thiorphan. 
     
     
         36 . The method of  claim 31 , wherein the agent is tixocortol. 
     
     
         37 . A method for increasing lipid secretion from a meibomian gland, comprising topically administering to the eyelid margin of the patient in need thereof an ophthalmic composition comprising an effective amount of a single agent which increases lipogenesis in the meibomian gland or increases lipid secretion from the meibomian gland, wherein the agent is thiorphan or tixocortol. 
     
     
         38 . The method of  claim 37 , further comprising the step of administering to the patient a keratolytic agent. 
     
     
         39 . The method of  claim 38 , wherein the keratolytic agent is selected from the group consisting of benzoyl peroxide, coal tar, dithranol, salicylic acid, selenium disulfide, alpha-hydroxy acid, urea, boric acid, retinoic acid, lactic acid, sodium thioglycolate or allantoin. 
     
     
         40 . The method of  claim 37 , wherein the agent is thiorphan. 
     
     
         41 . The method of  claim 37 , wherein the agent is tixocortol.